Cargando…
Co-lethality studied as an asset against viral drug escape: the HIV protease case
BACKGROUND: Co-lethality, or synthetic lethality is the documented genetic situation where two, separately non-lethal mutations, become lethal when combined in one genome. Each mutation is called a "synthetic lethal" (SL) or a co-lethal. Like invariant positions, SL sets (SL linked couples...
Autores principales: | Brouillet, Sophie, Valere, Thomas, Ollivier, Emmanuelle, Marsan, Laurent, Vanet, Anne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898770/ https://www.ncbi.nlm.nih.gov/pubmed/20565756 http://dx.doi.org/10.1186/1745-6150-5-40 |
Ejemplares similares
-
Synthetic lethals in HIV: ways to avoid drug resistance: Running title: Preventing HIV resistance
por: Petitjean, Michel, et al.
Publicado: (2015) -
A New Strategy to Reduce Influenza Escape: Detecting Therapeutic Targets Constituted of Invariance Groups
por: Lao, Julie, et al.
Publicado: (2017) -
Nanoantibiotics: strategic assets in the fight against drug-resistant superbugs
por: Khurana, Chandni, et al.
Publicado: (2018) -
CTL Escape and Viral Fitness in HIV/SIV Infection
por: Seki, Sayuri, et al.
Publicado: (2012) -
Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)